Bluesphere Advisors, LLC Edwards Lifesciences Corp Transaction History

Bluesphere Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $180,006 - $266,929	-2,081 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $139,583 - $175,697	-1,369 Reduced 39.68%	2,081 $245,000
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $139,583 - $175,697	1,369 Added 65.79%	3,450 $289,000
Q2 2021 Aug 11, 2021	SELL	$83.84 - $104.76 $114,776 - $143,416	-1,369 Reduced 39.68%	2,081 $216,000
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $247,330 - $314,743	3,450 New	3,450 $314,000

1,364

470M

9.76M

3.89M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Bluesphere Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bluesphere Advisors, LLC with notifications on news.